Intracellular expression of P-170 glycoprotein in peripheral blood mononuclear cell subsets from healthy donors and HIV-infected patients

Haematologica

Volumn 83, Issue 1, 1998, Pages 13-20

  Malorni, Walter ^a,b   Lucia, Mothanjie Barbara ^a   Rainaldi, Gabriella ^a   Cauda, Roberto ^a   Cianfriglia, Maurizio ^a   Donelli, Gianfranco ^a   Ortona, Luigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AIDS; HIV; Leukocyte; Multidrug resistance; P glycoprotein

Indexed keywords

ANTHRACYCLINE; ANTIRETROVIRUS AGENT; DRUG CARRIER; GLYCOPROTEIN GP 120; GLYCOPROTEIN P; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; VINCA ALKALOID; ZIDOVUDINE;

ADULT; ARTICLE; CELL MEMBRANE TRANSPORT; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG TRANSPORT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; INTRACELLULAR TRANSPORT; LYMPHOCYTE; MONONUCLEAR CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEIN MODIFICATION;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MALE; MICROSCOPY, FLUORESCENCE; P-GLYCOPROTEIN;

EID: 0031882085     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Roninson IB. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Publishing Corp., 1991.
2. McKenna SL, Padua RS. Multidrug resistance in leukemia. Br J Haematol 1997; 96:659-74.
3. Edincott JA, Ling V. The biochemistry of P-glycoprotein mediated multidrug resistance. Annu Rev Biochem 1989; 58:137-71.
4. Patriarca F, Melli C, Damiani D, et al. Plasma cell P170 expression and response to treatment in multiple myeloma. Haematologica 1996; 81:232-7.
5. Beck J, Niethammer D, Gekeler V. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias. Cancer Lett 1994; 86:135-42.
6. Thiebaut T, Tsruo T, Hamada H, Gottesman MM, Pastan I, Willingam MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987; 84:7735-8.
7. Juranka PF, Zastawny RL, Ling V. P-glycoprotein multidrug-resistance and a superfamily of membrane associated transport proteins. FASEB J 1989; 3:2583-92.
8. Blobe GC, Obeid LM, Hannun YA. Regulation of protein kinase C and role in cancer biology. Canc Metast Rev 1994; 13:411-31.
9. Coon JS, Ang Y, Bines SD, Markham PN, Chong ASF, Gebel HM. Multidrug resistance activity in human lymphocytes. Hum Immunol 1991; 32:134-40.
10. Drach D, Zhao S, Drach J, et al. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistance phenotype. Blood 1992; 80:2729-34.
11. + T cells: a role in cytotoxic effector function. J Clin Immunol 1992; 12:451-8.
12. Chong AS, Markham PN, Gebel HM, Bines SD, Coon JS. Diverse multidrug resistance modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immun 1993; 36:133-9.
13. Klimecki WT, Taylor CV, Dalton WS. Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer by verapamil isomers and cyclosporin A analogs. J Clin Immunol 1995; 15:152-8.
14. Lucia M, Cauda R, Landay AL, Malorni W, Donelli G, Ortona L. Transmembrane P-glycoprotein (Pgp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function. AIDS Res Hum Retrov 1995; 11:893-901.
15. Raghu G, Park SW, Roninson IB, Mechetner EB. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp Hematol 1996; 24:1258-64.
16. Antonelli G, Turriziani O, Cianfriglia M, et al. Resistance of HIV-1 to AZT might also involve expression of multidrug resistance P-glycoprotein. AIDS Res Hum Retrov 1992; 8:1839-44.
17. Gupta S, Gollapudi S. P-glycoprotein (MDR 1 gene product) in cells of the immune system: Its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J Clin Immunol 1993; 13:289-301.
18. Duesing TD, Slate DL. Intracellular expression of P-glycoprotein in a human colon tumor cell line. Anticancer Res 1994; 14:13-9.
19. Motinari A, Cianfriglia M, Meschini S, Calcabrini A, Arancia G. P-Glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int J Cancer 1994; 59:789-95.
20. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors. Proc Natl Acad Sci USA 1987; 84:265-9.
21. Kornfield H, Cruikshank WW, Pyle SW, Berman JS, Center DM. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 1988; 335:445-8.
22. + T-cell clones. J Virol 1991; 65:6277-82.
23. Cianfriglia M, Willingham MC, Tombesi M, Scagliotti GV, Frasca G, Chersi A. P-glycoprotein epitope mapping. I. Identification of linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM.4.17 murine monoclonal antibody to human multi-drug-resistant cells. Int J Cancer 1994; 56:153-60.
24. Longo R, Bensi L, Vecchi A, Messora C, Sacchi S. P-glycoprotein expression in acute myeloblastic leukemia analyzed by immunocytochemistry and flow cytometry. Leuk Lymphoma 1995; 17:121-5.
25. Pilarski LM, Cass CE, Tsuro T, Belch R. Multidrug resistance of a continously differentiating monoclonal B lineage in the blood and bone marrow of patients with multiple myeloma. Curr Top Microbiol Immunol 1992; 182:177-85.
26. Cumber PM, Jacobs A, Hoy T, et al. Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia. Br J Haematol 1990; 76:226-30.
27. Michieli M, Raspadori D, Damiani D, et al. The expression of the multidrug resistance associated glycoprotein in B-cell chronic lymphocytic leukaemia. Br J Haematol 1991; 79:50-5.
28. Sparrow RL, Hall FJ, Siregar H, Van Der Weyden MB. Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistance. Leuk Res 1993; 17:941-7.
29. Pilarski LM, Belch AR. Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: Implications for treatment. Leuk Lymphoma 1995; 17:367-74.
30. Kohno K, Sato SI, Takano H, Matuso KI, Kuwano M. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Comm 1989; 165:1415-21.
31. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992; 69:11-25.
32. Zhang JT, Ling V. Involvement of cytoplasmic factors regulatin the membrane orientation of P-glycoprotein sequences. Biochemistry 1995; 34:9159-65.
33. Chaudhary PM, Mechetner EV, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1992; 80:2735-9.
34. Pilarski LM, Belch AR. Circulating monoclonal B cells expressing P-glycoprotein may be a reservoir of multidrug resistant disease in multiple myeloma. Blood 1994; 83:724-36.
35. Monaco JJ, Cho S, Attaya M. Transport protein genes in the murine MHC: Possible implications for antigen processing. Science 1990; 250:1723-6.
36. Baiocchi M, Toffoli G. Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistance. Eur J Cancer 1992; 67:1099-105.
37. Masci AM, Scala S, Racioppi L, Zappacosta S. Cell surface experssion of major histocompatibility class I antigens is modulated by P-glycoprotein transporter. Hum Immunol 1995; 42:245-53.
38. Yusa K, Oh-hara T, Yamazaki A, Tsukahara S, Satoh W, Tsuruo T. Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cells. Biochem Biophys Res Comm 1990; 169:986-90.
39. Michieli M, Damiani D, Michelutti A, et al. Overcoming Pgp-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin. Haematologica 1996; 295-301.